Doctors have been trying for 30 years to develop a chemotherapy sensitivity test to identify the most effective chemotherapy drugs for an individual patient. At the 2012 San Antonio Breast Cancer Symposium, my partner Dr. Linda Bosserman and I presented the results of a national study that showed a new test, the MiCK Drug Induced Apoptosis assay, was able to help physicians choose…